ABV-1504
Phase 2- Indications
- Major Depressive Disorder
Company intelligence / Profile preview
LifeCode Biotechnology
Foster City, California, United Statessec.gov ↗
- Ownership
- Private
- Employees
- ~6
- Development stage
- Phase 2
01
Overview
Lifecode focuses on genomically driven, personalized cancer care through molecular tumor profiling. The company has developed platforms for analyzing genomic data to improve patient care.
- Therapeutic areas
- OncologyDermatology
- Modalities
- Genomic sequencingAI-powered drug discovery
- Industry
- Molecular Diagnostics
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
ElinextMayo ClinicResearch institutes in EuropeUniversities in Hong Kong and Taiwan
Beyond the preview
Go deeper on LifeCode Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LifeCode Biotechnology.